2010

Rheonix Announces Issuance of New Patent for its Microfluidic Diagnostic Platform

Ithaca, NY — November 17, 2010 — Rheonix, Inc., developer of the Rheonix CARD™ (Chemistry And Reagent Device) system to provide multiplexed endpoint analysis for a wide breadth of diagnostic applications, announced that on November 16, 2010 the U.S. Patent and Trademark Office issued Patent Number 7,832,429 "Microfluidic Pump and Valve Structures and Fabrication Method” to the Company. The patent is the first granted for the Company’s core device, which… Read More »

Rheonix Receives Additional $233K Award from National Institutes of Health

Ithaca, N.Y. — August 17, 2010 — Rheonix, Inc. today announced that the National Institutes of Health has added a $233,044 supplement to its previously awarded Point-of-Care Partnership grant. The POC Partnership grant is funded to develop a fully automated molecular diagnostic for the detection of multiple sexually transmitted infections (STI). The supplement, awarded under the American Recovery and Reinvestment Act (ARRA) of 2009, was added to expand the scope… Read More »

Rheonix CARD™ Technology Demonstrates Utility in Multiple Molecular Diagnostic Applications at AACC Annual Meeting

Ithaca, NY — July 27, 2010 — Rheonix, Inc. today announced positive results from three separate studies of the Rheonix CARD™ (Chemistry And Reagent Device) system presented in poster sessions at the American Association for Clinical Chemistry (AACC) Annual Meeting held in Anaheim, CA, July 25-29, 2010. The data presented demonstrate the utility of the Rheonix CARD™ system as a powerful, analytic platform for the life science industry. In studies… Read More »

Rheonix, Inc. Completes $12.6 Million Series A Financing

Ithaca, NY — April 21, 2010 — Rheonix, Inc. today announced the completion of a $12.6 million Series A financing to continue development of the Rheonix CARD™ (Chemistry And Reagent Device) system. This powerful, analytic platform for the lifescience industry vertically integrates all the functions of traditional molecular diagnostic instrumentation into a single system to achieve unprecedented raw sample preparation, molecular amplification and multiplex analysis. The Rheonix CARD system provides… Read More »

National Institutes of Health Renews Partnership with Rheonix and Awards Additional Grant to Develop CARD™ Technology for Simultaneous Detection of Multiple Sexually Transmitted Infectious Agents

Ithaca, N.Y. — April 16, 2010 — Rheonix, Inc. today announced that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), continues to support its Point-of-Care Partnership with Rheonix for a second year. As part of the grant, Rheonix will receive an additional $396,775 award to optimize its CARD™ (Chemistry And Reagent Device) diagnostic platform for simultaneous, multiplex, point-ofcare detection of the… Read More »

Rheonix Receives Additional Funding from U.S. National Science Foundation and NYSERDA to Develop a Recreational Water Test

Ithaca, N.Y. — Tuesday, January 19, 2010 — Rheonix, Inc. today announced the receipt of a National Science Foundation (NSF) Small Business Innovation Research Phase IB grant. The award decision recognizes the substantial progress made by Rheonix during the NSF-funded Phase I program to develop a rapid biosensor to monitor recreational water safety and the Company’s ability to attract significant funding from the New York State Energy Research and Development… Read More »

Rheonix Announces Patent for its Microfluidic Lamination Technology

Ithaca, NY — Tuesday, January 12, 2010 — Rheonix, Inc. announced that on October 27, 2009 the U. S. Patent and Trademark Office issued Patent Number 7,608,160, Laminated Microfluidic Structures and Method for Making, the first grant of U. S. patent rights for the Company’s microfluidic lamination technology. A patent claiming the same technology has also issued in China. “These patents recognize the unique contribution that inventors Dr. Peng Zhou and… Read More »